Libtayo 350 MG/7 ML vial 7ML
Ended Awarded
- Contract number
- SPE2DB25FKNCY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,553
Award facts
- Contract value 100% obligated
- $19,553.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,553.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LIBTAYO 350 mg/7 ml vials on August 6, 2025, with an ultimate completion date of August 27, 2025. LIBTAYO (cemiplimab) is a monoclonal antibody immunotherapy used primarily for oncology indications. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, providing critical pharmaceutical products and medical supplies to support military healthcare systems globally. The company's substantial IDC vehicle enables flexible delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for LIBTAYO reflects AmerisourceBergen's ongoing role as a key pharmaceutical distributor supporting the Defense Department's medical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FKNCY?
SPE2DB25FKNCY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FKNCY worth?
The government has obligated $19,553 on SPE2DB25FKNCY.
Is contract SPE2DB25FKNCY an order under another contract?
Yes. SPE2DB25FKNCY is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKNCY competed?
The extent of competition for SPE2DB25FKNCY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award